Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The research hypothesis of this study is: In patients with moderate to severe cancer related
pain, the addition of low dose methadone to an existing opioid significantly reduces pain
severity compared to low doses morphine.
Phase:
Phase 3
Details
Lead Sponsor:
McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre